These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31150846)
1. Clinicopathological and Genetic Features of Supratentorial Cortical Ependymomas. Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Date I World Neurosurg; 2019 Sep; 129():e417-e428. PubMed ID: 31150846 [TBL] [Abstract][Full Text] [Related]
2. Supratentorial Cortical Ependymomas: A Retrospective Series of 13 Cases at a Single Center. Wang M; Zhang R; Liu X; Li D; Zhao P; Zuo Y; Zhang P; Wang J; Sun H World Neurosurg; 2018 Apr; 112():e772-e777. PubMed ID: 29408575 [TBL] [Abstract][Full Text] [Related]
3. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases. Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268 [TBL] [Abstract][Full Text] [Related]
4. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin. Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850 [TBL] [Abstract][Full Text] [Related]
8. Supratentorial ependymoma in childhood: more than just RELA or YAP. Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105 [TBL] [Abstract][Full Text] [Related]
9. The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study. Wang L; Han S; Yan C; Yang Y; Li Z; Yang Z J Cancer Res Clin Oncol; 2021 Apr; 147(4):1259-1270. PubMed ID: 33387039 [TBL] [Abstract][Full Text] [Related]
10. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077 [TBL] [Abstract][Full Text] [Related]
12. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features. Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956 [TBL] [Abstract][Full Text] [Related]
13. Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study. Wang Q; Cheng J; Zhang S; Li Q; Hui X; Ju Y Neurosurg Rev; 2021 Jun; 44(3):1543-1551. PubMed ID: 32607870 [TBL] [Abstract][Full Text] [Related]
14. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors. Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745 [TBL] [Abstract][Full Text] [Related]
15. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma. Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087 [TBL] [Abstract][Full Text] [Related]
16. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology. Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023 [TBL] [Abstract][Full Text] [Related]
17. Characterization of molecular signatures of supratentorial ependymomas. Torre M; Alexandrescu S; Dubuc AM; Ligon AH; Hornick JL; Meredith DM Mod Pathol; 2020 Jan; 33(1):47-56. PubMed ID: 31375768 [TBL] [Abstract][Full Text] [Related]
18. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523 [TBL] [Abstract][Full Text] [Related]
19. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284 [TBL] [Abstract][Full Text] [Related]